Mitral Valve Prolapse Clinical Trial
Official title:
Automatic Differentiation of Innocent and Pathologic Murmurs in Pediatrics
The purpose of this preliminary clinical study is to assess the quality of a computational
algorithm that automatically classifies murmurs of phonocardiograms (PCGs) as either
pathologic (AHA class I) or as no- or innocent (AHA class III) in the pediatric population.
Each patient is auscultated and diagnosed independently by a medical specialist by means of a
standard mechanical stethoscope. Additionally, for each patient, a PCG is recorded using a
Littmann 3200 electronic stethoscope and later analyzed using the computational algorithm. An
echocardiogram is performed as the gold-standard for determining heart pathologies. The
results of the computer aided auscultation (CAA) are compared to the findings of the medical
professionals as well as to the echocardiogram findings.
Hypothesis: The specific CAA algorithms used in this study are able to differentiate
pathologic (AHA class I) from no- or innocent murmurs (AHA class III) in a pediatric
population.
Background:
Computer aided auscultation in the differentiation of pathologic (AHA class I) from no- or
innocent murmurs (AHA class III) would be of great value to the general practitioner and
potentially also to the specialist. This would allow objective screening for structural heart
disease, standardized documentation of auscultation findings, and may avoid unnecessary
referrals to pediatric cardiologists. Our goal was to further develop and assess the quality
of a novel computational algorithm that automatically classifies murmurs of phonocardiograms
(PCGs) acquired in a pediatric population.
Methods:
Patients with no-, innocent-, and pathologic murmurs were recruited from the general
pediatric cardiology clinic. Using an electronic stethoscope, PCGs were acquired by the
pediatric cardiologist from each patient. The PCGs were analyzed by the algorithm and
diagnoses were compared to findings by the pediatric specialist and echocardiography as the
gold standard.
The following registry procedures and quality factors have been implemented in this
preliminary clinical study:
- Quality assurance plan, including
- data validation
- proper registration procedures
- Source data verification to assess the accuracy, completeness, or representativeness of
registry data by comparing the data to external data sources (medical records and paper
case report forms).
- Standard Operating Procedures to address registry operations and analysis activities,
including patient recruitment, data collection, data management, data analysis.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT02499419 -
Exercise Capacity Evaluation in Patients With Non-rheumatic Mitral Valve Prolapse (MVP)
|
N/A | |
| Completed |
NCT02105480 -
Automated Algorithm Based Analysis of Phonocardiograms of Newborns
|
||
| Enrolling by invitation |
NCT04067635 -
Primary Mitral Regurgitation Repair
|
||
| Recruiting |
NCT06378996 -
Arrhythmic Mitral Valve Prolapse Detection Using Long-term Ambulatory Rhythm Monitoring
|
N/A | |
| Terminated |
NCT03285724 -
Safety and Performance Study of the Harpoon Mitral Valve Repair System
|
N/A | |
| Recruiting |
NCT03506217 -
Using Pulse Counter Vigileo-Flotrac System in Transapical Off-pump Minimally Invasive Mitral Valve Repair
|
||
| Completed |
NCT00665301 -
Cardiac Output Pulmonary Arterial Catheter Compared to FloWave™ 1000
|
N/A | |
| Not yet recruiting |
NCT04299334 -
Neochordae Technique in Mitral Valve Repair
|
Phase 1 | |
| Completed |
NCT03470155 -
Operative Mitral Valve Reconstruction in Functional mv Insufficiency With Reduced Systolic Ventricle Function
|
||
| Recruiting |
NCT06341166 -
Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse
|
||
| Completed |
NCT04231903 -
Myocardial Protection in Minimally Invasive Mitral Valve Surgery
|
||
| Not yet recruiting |
NCT03609931 -
Patient Specific Mitral Valve Modeling for Surgical Planning and Training
|
||
| Recruiting |
NCT05631730 -
Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse
|
Phase 3 | |
| Recruiting |
NCT02552771 -
The Canadian Mitral Research Alliance (CAMRA) Trial CardioLink-2
|
N/A | |
| Recruiting |
NCT01719211 -
Genetic Basis of Mitral Valve Prolapse
|
||
| Recruiting |
NCT06255457 -
Arrhythmogenic Mitral Valve Disease in Patients Undergoing Mitral Valve Surgery
|
||
| Recruiting |
NCT04190602 -
Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System
|
||
| Recruiting |
NCT03113552 -
Prognostic Impact of the Location of Mitral Valve Prolapse on the Long-term Results of Mitral Plasty
|
||
| Completed |
NCT02771275 -
Safety and Early Feasibility Study of the Harpoon Medical Device (EFS)
|
N/A | |
| Recruiting |
NCT05562804 -
Mitral Valve Prolapse, Arrhythmias and Mitral Valve Surgery
|